Jefferies Financial Group Inc. Uni Qure N.V. Transaction History

Jefferies Financial Group Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$11.12 - $22.2 $278,000 - $555,000	25,000 New	25,000 $286,000
Q4 2022 Sep 21, 2023	SELL	$18.12 - $27.32 $185,730 - $280,030	-10,250 Reduced 41.0%	14,750 $334,000
Q4 2022 Feb 14, 2023	BUY	$18.12 - $27.32 $267,270 - $402,970	14,750 New	14,750 $334,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.